Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer

Identification of predictive biomarkers for ovarian cancer (OC) treatment, particularly in the platinum-resistant/refractory setting, is highly relevant for clinical management. E-cadherin, vimentin, and osteopontin (OPN) are proteins associated with tumor microenvironment (TME) remodelling that pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Dionísio de Sousa, Isabel J., Marques, Durval S., Príncipe, Catarina, Portugal, Raquel V., Canberk, Sule, Prazeres, Hugo, Lopes, José M., Gimba, Etel R. P., Lima, Raquel T., Soares, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459532/
https://www.ncbi.nlm.nih.gov/pubmed/32731632
http://dx.doi.org/10.3390/diagnostics10080525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459532/
https://www.ncbi.nlm.nih.gov/pubmed/32731632
http://dx.doi.org/10.3390/diagnostics10080525

Ejemplares similares